Cite
HARVARD Citation
Zheng, Y. et al. (n.d.). 1188PIdentification of prognostic and predictive factors for durvalumab efficacy by modeling of tumor response and overall survival (OS) in patients with non-small cell lung cancer (NSCLC). Annals of oncology. p. . [Online].